Polyneuropathy In Amyloidosis — Patent Landscape
1
Approved drugs
13
Active US patents
64/100
Avg vulnerability
$700M
Annual revenue covered
Originators in Polyneuropathy In Amyloidosis
Cliff calendar — next 15 years
1
27
8
29
2
30
1
32
1
35
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Onpattro
PATISIRAN SODIUM
|
Alnylam Pharmaceuticals | 13 | 64 | $700M | 2027-10-03 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9364435 | Onpattro | method of use | 75 | 2029-04-15 |
| 8822668 | Onpattro | method of use | 75 | 2029-04-15 |
| 10240152 | Onpattro | method of use | 68 | 2029-10-20 |
| 9234196 | Onpattro | method of use | 68 | 2029-10-20 |
| 8741866 | Onpattro | method of use | 68 | 2029-10-20 |
| 8802644 | Onpattro | method of use | 68 | 2030-10-21 |
| 8158601 | Onpattro | method of use | 68 | 2030-11-10 |
| 8168775 | Onpattro | method of use | 62 | 2032-08-10 |
| 11079379 | Onpattro | method of use | 62 | 2035-08-27 |
| 8642076 | Onpattro | formulation | 55 | 2027-10-03 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 11141378 | Onpattro | formulation | 55 | 2029-04-15 |
| 8492359 | Onpattro | formulation | 55 | 2029-04-15 |
| 8058069 | Onpattro | formulation | 55 | 2029-04-15 |
| 8642076 | Onpattro | formulation | 55 | 2027-10-03 |
| 11079379 | Onpattro | method of use | 62 | 2035-08-27 |
| 8168775 | Onpattro | method of use | 62 | 2032-08-10 |
| 8158601 | Onpattro | method of use | 68 | 2030-11-10 |
| 8802644 | Onpattro | method of use | 68 | 2030-10-21 |
| 9234196 | Onpattro | method of use | 68 | 2029-10-20 |
| 10240152 | Onpattro | method of use | 68 | 2029-10-20 |
Related
- Polyneuropathy In Amyloidosis — full disease profile
- AI Patent Landscape Report — type "polyneuropathy in amyloidosis" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner